Drugplain

Fiasp 100 [iU]/mL

insulin aspart injection · INJECTION, SOLUTION · Novo Nordisk

No Recall HistoryCurrently in Shortage
Plain English

Fiasp is a fast-acting insulin injection used to help control blood sugar in people with diabetes. It is given as a shot under the skin and works quickly to lower blood sugar levels after meals.

Key Facts

Brand Name
Fiasp
Generic Name
insulin aspart injection
NDC Code (Product)
0169-3201
Manufacturer
Novo Nordisk
Strength
100 [iU]/mL
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Marketing Status
Application #
BLA208751
Drug Class
Insulin Analog [EPC]
Marketing Start
10/20/2017

Recall History

No Recall History

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

blood glucose increased1,024 reports
nausea744 reports
dyspnoea703 reports
hypoglycaemia658 reports
vomiting656 reports
off label use637 reports
drug ineffective583 reports
abdominal pain501 reports
diarrhoea494 reports
fatigue488 reports

Frequently Asked Questions

What is Fiasp used for?

Fiasp is a fast-acting insulin injection used to help control blood sugar in people with diabetes. It is given as a shot under the skin and works quickly to lower blood sugar levels after meals.

Is Fiasp a controlled substance?

Fiasp is not classified as a controlled substance by the DEA.

What is the generic name for Fiasp?

The generic name for Fiasp is insulin aspart injection. There are no other listed brand versions of insulin aspart injection.

What is the NDC code for Fiasp 100 [iU]/mL?

The NDC (National Drug Code) for Fiasp 100 [iU]/mL is 0169-3201, listed by Novo Nordisk.

Product NDC

0169-3201

Package NDC

0169-3201-11

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)